These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 39132669)

  • 21. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
    Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
    J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations.
    Periwal N; Rathod SB; Sarma S; Johar GS; Jain A; Barnwal RP; Srivastava KR; Kaur B; Arora P; Sood V
    Microbiol Spectr; 2022 Oct; 10(5):e0121922. PubMed ID: 36069583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting Distribution of SARS-CoV-2 Lineages across Multiple Rounds of Pandemic Waves in West Bengal, the Gateway of East and North-East States of India.
    Singh AK; Laskar R; Banerjee A; Mondal RK; Gupta B; Deb S; Dutta S; Patra S; Ghosh T; Sarkar S; Ghosh S; Bhattacharya S; Roy D; Chakraborty A; Chowdhury M; Mahaptra S; Paul A; Mazumder A; Chowdhury A; Chatterjee SS; Sarkar A; Ray R; Pal K; Jana A; Barik G; Ganguly S; Chatterjee M; Majhi D; Bandopadhyay B; Das S; Maitra A; Biswas NK
    Microbiol Spectr; 2022 Aug; 10(4):e0091422. PubMed ID: 35852336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.
    Islam MA; Shahi S; Marzan AA; Amin MR; Hasan MN; Hoque MN; Ghosh A; Barua A; Khan A; Dhama K; Chakraborty C; Bhattacharya P; Wei DQ
    Front Pharmacol; 2023; 14():1090717. PubMed ID: 36825152
    [No Abstract]   [Full Text] [Related]  

  • 25. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2.
    van Dorp L; Acman M; Richard D; Shaw LP; Ford CE; Ormond L; Owen CJ; Pang J; Tan CCS; Boshier FAT; Ortiz AT; Balloux F
    Infect Genet Evol; 2020 Sep; 83():104351. PubMed ID: 32387564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete Genomic Characterisation and Mutation Patterns of Iraqi SARS-CoV-2 Isolates.
    Ahmed JQ; Maulud SQ
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inferring selection effects in SARS-CoV-2 with Bayesian Viral Allele Selection.
    Jankowiak M; Obermeyer FH; Lemieux JE
    PLoS Genet; 2022 Dec; 18(12):e1010540. PubMed ID: 36508459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of SARS-CoV-2 phylogenies.
    Turakhia Y; De Maio N; Thornlow B; Gozashti L; Lanfear R; Walker CR; Hinrichs AS; Fernandes JD; Borges R; Slodkowicz G; Weilguny L; Haussler D; Goldman N; Corbett-Detig R
    PLoS Genet; 2020 Nov; 16(11):e1009175. PubMed ID: 33206635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?
    Menasria T; Aguilera M
    Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
    Ghorbani A; Samarfard S; Ramezani A; Izadpanah K; Afsharifar A; Eskandari MH; Karbanowicz TP; Peters JR
    Infect Genet Evol; 2020 Nov; 85():104556. PubMed ID: 32937193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phylogenetic classification of the whole-genome sequences of SARS-CoV-2 from India & evolutionary trends.
    Potdar V; Vipat V; Ramdasi A; Jadhav S; Pawar-Patil J; Walimbe A; Patil SS; Choudhury ML; Shastri J; Agrawal S; Pawar S; Lole K; Abraham P; Cherian S;
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):166-174. PubMed ID: 33818474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences.
    O'Toole Á; Pybus OG; Abram ME; Kelly EJ; Rambaut A
    BMC Genomics; 2022 Feb; 23(1):121. PubMed ID: 35148677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
    Laha S; Chakraborty J; Das S; Manna SK; Biswas S; Chatterjee R
    Infect Genet Evol; 2020 Nov; 85():104445. PubMed ID: 32615316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner.
    Wang X; Hu M; Liu B; Xu H; Jin Y; Wang B; Zhao Y; Wu J; Yue J; Ren H
    Front Cell Infect Microbiol; 2023; 13():1161445. PubMed ID: 37153142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G
    J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.